Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He FJ, Sun X, Thomas RG, Aisen PS, Siemers E, Sethuraman G, Nohs R, for the Alzheimer's Disease Cooperative Study Steering Committee on the Semagacestat Study Group. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med 2013;369:341-50. [Ref.ID 95879]
2. Cita con resumen
Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology 2011;77:556-63. [Ref.ID 91040]
3.Tiene citas relacionadas Cita con resumen
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack Jr CR, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disese. A randomized trial. JAMA 2010;304:1903-11. [Ref.ID 89570]
4. Cita con resumen
Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ, for the Alzheimer Disease Cooperative Study. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease. A randomized controlled trial. JAMA 2008;300:1774-83. [Ref.ID 84213]
5.Tiene citas relacionadas Cita con resumen
Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D, on behalf of the dimebon investigators. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 2008;372:207-15. [Ref.ID 83623]
6.Tiene citas relacionadas Cita con resumen
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey AS, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, for the Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88. [Ref.ID 74029]
7.Tiene citas relacionadas Cita con resumen
Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Daivs KL, Farlow MR, Jin S, Thomas RG, Thal LJ, for the Alzheimer's Disease Cooperative Study. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression. A randomized controlled trial. JAMA 2003;289:2819-26. [Ref.ID 66501]
8.Tiene citas relacionadas
Sano M, Thomas RG, Thal LJ. Alpha-tocopherol and Alzheimer's disease. The authors reply. N Engl J Med 1997;337:573. [Ref.ID 34671]
9.Tiene citas relacionadas Cita con resumen
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ, for the Members of the Alzheimer's Disease Cooperative Study. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-22. [Ref.ID 31704]
Seleccionar todas
 
 1 a 9 de 9